Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07574138
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center Ho Chi Minh City (UMC)Recruiting
NCT07574138Recruiting
—
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07573488
Sleep, Stress and Migraine - an Observational and Training StudySusanne WegenerRecruitingNot Applicable
NCT07573488Recruiting
Not Applicable
Sleep, Stress and Migraine - an Observational and Training StudySusanne Wegener
NCT07573046
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic DisordersHospices Civils de LyonNot Yet Recruiting
NCT07573046Not Yet Recruiting
—
Validation Study of the ExéSem Battery Designed to Differentiate the Contributio...Hospices Civils de Lyon
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573293
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional AthletesCairo UniversityCompletedNot Applicable
NCT07573293Completed
Not Applicable
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athlet...Cairo University
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07573501
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive ImpairmentKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573501Not Yet Recruiting
Not Applicable
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates...Ke Dong, MD
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
NCT07574151
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease SurveillanceUniversity of NottinghamRecruiting
NCT07574151Recruiting
—
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on...University of Nottingham
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07572825
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-KoziczNot Yet RecruitingPhase 1
NCT07572825Not Yet Recruiting
Phase 1
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-Kozicz
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Unknown1 (5%)
Active, not recruiting1 (5%)
Completed1 (5%)
not_applicable9 (45%)
Not Specified7 (35%)
Phase 22 (10%)
Early Phase 11 (5%)
Phase 11 (5%)